Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: OVARIAN CANCER RESEARCH FUND ALLIANCE
Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.
Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: OVARIAN CANCER RESEARCH FUND ALLIANCE
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
OVARIAN CANCER RESEARCH FUND ALLIANCE via OVARIAN CANCER RESEARCH FUND ALLIANCE
2022 · third_quarter · Q3
Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.
Supporting ongoing appropriations for ovarian cancer related programs within NCI, CDC and DoD.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.
Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: OVARIAN CANCER RESEARCH FUND ALLIANCE
Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.
Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: OVARIAN CANCER RESEARCH FUND ALLIANCE
Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.
To amend the Public Health Service Act to reauthorize Johanna's Law, and for other purposes.
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: OVARIAN CANCER RESEARCH FUND ALLIANCE
Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.
To amend the Public Health Service Act to reauthorize Johanna's Law, and for other purposes.
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: OVARIAN CANCER RESEARCH FUND ALLIANCE
Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.
To amend the Public Health Service Act to reauthorize Johanna's Law, and for other purposes.
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: OVARIAN CANCER RESEARCH FUND ALLIANCE
Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.
To amend the Public Health Service Act to reauthorize Johanna's Law, and for other purposes.
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: OVARIAN CANCER RESEARCH FUND ALLIANCE
Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.
SAFE Bridges Act of 2021
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: OVARIAN CANCER RESEARCH FUND ALLIANCE
Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.
SAFE Bridges Act of 2021
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: OVARIAN CANCER RESEARCH FUND ALLIANCE
Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.
SAFE Bridges Act of 2021
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: OVARIAN CANCER RESEARCH FUND ALLIANCE
Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.
SAFE Bridges Act of 2021
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: OVARIAN CANCER RESEARCH FUND ALLIANCE
Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.
Telehealth Modernization Act
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: OVARIAN CANCER RESEARCH FUND ALLIANCE
Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.
Telehealth Modernization Act
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: OVARIAN CANCER RESEARCH FUND ALLIANCE
Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.
Telehealth Modernization Act
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: OVARIAN CANCER RESEARCH FUND ALLIANCE
Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.
Telehealth Modernization Act
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: OVARIAN CANCER RESEARCH FUND ALLIANCE
Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.
Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: OVARIAN CANCER RESEARCH FUND ALLIANCE
Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine.
Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: OVARIAN CANCER RESEARCH FUND ALLIANCE
Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.
Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: OVARIAN CANCER RESEARCH FUND ALLIANCE
Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.
Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: OVARIAN CANCER RESEARCH FUND ALLIANCE
Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.
To amend the Public Health Service Act to reauthorize Johanna's Law, and for other purposes.
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: OVARIAN CANCER RESEARCH FUND ALLIANCE
Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.
To amend the Public Health Service Act to reauthorize Johanna's Law, and for other purposes.
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: OVARIAN CANCER RESEARCH FUND ALLIANCE
Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.
To amend the Public Health Service Act to reauthorize Johanna's Law, and for other purposes.
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: OVARIAN CANCER RESEARCH FUND ALLIANCE
Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.
SAFE Bridges Act of 2021
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: OVARIAN CANCER RESEARCH FUND ALLIANCE
Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.
SAFE Bridges Act of 2021
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: OVARIAN CANCER RESEARCH FUND ALLIANCE
Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine.
SAFE Bridges Act of 2021
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: OVARIAN CANCER RESEARCH FUND ALLIANCE
Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.
SAFE Bridges Act of 2021
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: OVARIAN CANCER RESEARCH FUND ALLIANCE
Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.
Telehealth Modernization Act
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: OVARIAN CANCER RESEARCH FUND ALLIANCE
Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.
Telehealth Modernization Act
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: OVARIAN CANCER RESEARCH FUND ALLIANCE
Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.
Telehealth Modernization Act
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: OVARIAN CANCER RESEARCH FUND ALLIANCE
Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.
Telehealth Modernization Act
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: OVARIAN CANCER RESEARCH FUND ALLIANCE
Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine.
To amend the Public Health Service Act to reauthorize Johanna's Law, and for other purposes.
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: OVARIAN CANCER RESEARCH FUND ALLIANCE
Supporting passage of H.R.4560 To amend the Public Health Service Act to reauthorize Johanna's Law, and for other purposes. Supporting passage of H.R.913 the CLINICAL TREATMENT Act.
To amend the Public Health Service Act to reauthorize Johanna's Law, and for other purposes.
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: OVARIAN CANCER RESEARCH FUND ALLIANCE
Supporting passage of H.R.4560 To amend the Public Health Service Act to reauthorize Johanna's Law, and for other purposes. Supporting passage of H.R.913 the CLINICAL TREATMENT Act.
To amend the Public Health Service Act to reauthorize Johanna's Law, and for other purposes.
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: OVARIAN CANCER RESEARCH FUND ALLIANCE
Supporting passage of H.R.4560 To amend the Public Health Service Act to reauthorize Johanna's Law, and for other purposes. Supporting passage of H.R.913 the CLINICAL TREATMENT Act.
To amend the Public Health Service Act to reauthorize Johanna's Law, and for other purposes.
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: OVARIAN CANCER RESEARCH FUND ALLIANCE
Supporting passage of H.R.4560 To amend the Public Health Service Act to reauthorize Johanna's Law, and for other purposes. Supporting passage of H.R.913 the CLINICAL TREATMENT Act.
CLINICAL TREATMENT Act
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: OVARIAN CANCER RESEARCH FUND ALLIANCE
Supporting passage of H.R.4560 To amend the Public Health Service Act to reauthorize Johanna's Law, and for other purposes. Supporting passage of H.R.913 the CLINICAL TREATMENT Act.
CLINICAL TREATMENT Act
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: OVARIAN CANCER RESEARCH FUND ALLIANCE
Supporting passage of H.R.4560 To amend the Public Health Service Act to reauthorize Johanna's Law, and for other purposes. Supporting passage of H.R.913 the CLINICAL TREATMENT Act.
CLINICAL TREATMENT Act
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: OVARIAN CANCER RESEARCH FUND ALLIANCE
Supporting passage of H.R.4560 To amend the Public Health Service Act to reauthorize Johanna's Law, and for other purposes. Supporting passage of H.R.913 the CLINICAL TREATMENT Act.
CLINICAL TREATMENT Act
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: OVARIAN CANCER RESEARCH FUND ALLIANCE
Supporting passage of H.R.4560 To amend the Public Health Service Act to reauthorize Johanna's Law, and for other purposes. Supporting passage of H.R.913 the CLINICAL TREATMENT Act.
Cancer Drug Parity Act of 2019
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: OVARIAN CANCER RESEARCH FUND ALLIANCE
Supporting increased funding for CDMRP's OCRP in FY2020 Defense appropriations Support for increased funding fro ovarian cancer reserach and surveillance in FY2020 Labor-HHS-Ed appropriations (no bill # yet) Supporting the introduction of Access to Genetic Counselor Services Act Pursuing additional cosponasors and hearing for Cancer Drug Parity Act of 2019 (S.741/H.R.1730) Pursuing support for CLINICAL TREATMENT Act (H.R.913)
To amend the Public Health Service Act to reauthorize Johanna's Law, and for other purposes.
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: OVARIAN CANCER RESEARCH FUND ALLIANCE
Supporting passage of H.R.4560 To amend the Public Health Service Act to reauthorize Johanna's Law, and for other purposes. Supporting passage of H.R.913 the CLINICAL TREATMENT Act.
To amend the Public Health Service Act to reauthorize Johanna's Law, and for other purposes.
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: OVARIAN CANCER RESEARCH FUND ALLIANCE
Supporting passage of H.R.4560 To amend the Public Health Service Act to reauthorize Johanna's Law, and for other purposes. Supporting passage of H.R.913 the CLINICAL TREATMENT Act.
CLINICAL TREATMENT Act
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: OVARIAN CANCER RESEARCH FUND ALLIANCE
Supporting increased funding for CDMRP's OCRP in FY2020 Defense appropriations Support for increased funding fro ovarian cancer reserach and surveillance in FY2020 Labor-HHS-Ed appropriations (no bill # yet) Supporting the introduction of Access to Genetic Counselor Services Act Pursuing additional cosponasors and hearing for Cancer Drug Parity Act of 2019 (S.741/H.R.1730) Pursuing support for CLINICAL TREATMENT Act (H.R.913)
CLINICAL TREATMENT Act
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: OVARIAN CANCER RESEARCH FUND ALLIANCE
Supporting passage of H.R.4560 To amend the Public Health Service Act to reauthorize Johanna's Law, and for other purposes. Supporting passage of H.R.913 the CLINICAL TREATMENT Act.
CLINICAL TREATMENT Act
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: OVARIAN CANCER RESEARCH FUND ALLIANCE
Supporting passage of H.R.4560 To amend the Public Health Service Act to reauthorize Johanna's Law, and for other purposes. Supporting passage of H.R.913 the CLINICAL TREATMENT Act.
Cancer Drug Parity Act of 2019
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: OVARIAN CANCER RESEARCH FUND ALLIANCE
Supporting increased funding for CDMRP's OCRP in FY2020 Defense appropriations Support for increased funding fro ovarian cancer reserach and surveillance in FY2020 Labor-HHS-Ed appropriations (no bill # yet) Supporting the introduction of Access to Genetic Counselor Services Act Pursuing additional cosponasors and hearing for Cancer Drug Parity Act of 2019 (S.741/H.R.1730) Pursuing support for CLINICAL TREATMENT Act (H.R.913)
Cancer Drug Parity Act of 2017
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: OVARIAN CANCER RESEARCH FUND ALLIANCE
FY19 Appropriations for NIH, CDC, and DoD ovarian cancer programs. Supporting H.R.1409 - Cancer Drug Parity Act of 2017. Supporting the re-authorization of Johanna's Law.
Cancer Drug Parity Act of 2017
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: OVARIAN CANCER RESEARCH FUND ALLIANCE
FY19 Appropriations for NIH, CDC, and DoD ovarian cancer programs. Supporting H.R.1409 - Cancer Drug Parity Act of 2017. Supporting the re-authorization of Johanna's Law.
Cancer Drug Parity Act of 2017
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: OVARIAN CANCER RESEARCH FUND ALLIANCE
FY18 and FY19 Appropriations for NIH, CDC, and DoD ovarian cancer programs. Supporting H.R.1409 - Cancer Drug Parity Act of 2017. Supporting the re-authorization of Johanna's Law.
Cancer Drug Parity Act of 2017
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: OVARIAN CANCER RESEARCH FUND ALLIANCE
FY19 Appropriations for NIH, CDC, and DoD ovarian cancer programs. Supporting H.R.1409 - Cancer Drug Parity Act of 2017. Supporting the re-authorization of Johanna's Law.
Cancer Drug Parity Act of 2017
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: OVARIAN CANCER RESEARCH FUND ALLIANCE
FY17 and FY18 Appropriations for NIH, CDC, and DoD ovarian cancer programs. Supporting H.R.1409 - Cancer Drug Parity Act of 2017.
Cancer Drug Parity Act of 2017
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: OVARIAN CANCER RESEARCH FUND ALLIANCE
FY17 and FY18 Appropriations for NIH, CDC, and DoD ovarian cancer programs. Supporting H.R.1409 - Cancer Drug Parity Act of 2017.
Cancer Drug Parity Act of 2017
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: OVARIAN CANCER RESEARCH FUND ALLIANCE
FY17 and FY18 Appropriations for NIH, CDC, and DoD ovarian cancer programs. Supporting H.R.1409 - Cancer Drug Parity Act of 2017.
Cancer Drug Parity Act of 2017
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: OVARIAN CANCER RESEARCH FUND ALLIANCE
FY17 and FY18 Appropriations for NIH, CDC, and DoD ovarian cancer programs. Supporting H.R.1409 - Cancer Drug Parity Act of 2017.
OVARIAN CANCER RESEARCH FUND ALLIANCE via OVARIAN CANCER RESEARCH FUND ALLIANCE
2022 · third_quarter · Q3
Supporting ongoing appropriations for ovarian cancer related programs within NCI, CDC and DoD.
Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
OVARIAN CANCER RESEARCH FUND ALLIANCE via OVARIAN CANCER RESEARCH FUND ALLIANCE
2022 · second_quarter · Q2
Supporting ongoing appropriations for ovarian cancer related programs within NCI, CDC and DoD.
Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
OVARIAN CANCER RESEARCH FUND ALLIANCE via OVARIAN CANCER RESEARCH FUND ALLIANCE
2022 · first_quarter · Q1
Supporting ongoing appropriations for ovarian cancer related programs within NCI, CDC and DoD.
Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
OVARIAN CANCER RESEARCH FUND ALLIANCE via OVARIAN CANCER RESEARCH FUND ALLIANCE
2021 · fourth_quarter · Q4
Supporting ongoing appropriations for ovarian cancer related programs within NCI, CDC and DoD.
Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
OVARIAN CANCER RESEARCH FUND ALLIANCE via OVARIAN CANCER RESEARCH FUND ALLIANCE
2021 · third_quarter · Q3
Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.
Supporting ongoing appropriations for ovarian cancer related programs within NCI, CDC and DoD.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
OVARIAN CANCER RESEARCH FUND ALLIANCE via OVARIAN CANCER RESEARCH FUND ALLIANCE
2021 · second_quarter · Q2
Supporting ongoing appropriations for ovarian cancer related programs within NCI, CDC and DoD.
Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
OVARIAN CANCER RESEARCH FUND ALLIANCE via OVARIAN CANCER RESEARCH FUND ALLIANCE
2021 · first_quarter · Q1
Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine.
Supporting ongoing appropriations for ovarian cancer related programs within NCI, CDC and DoD.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
OVARIAN CANCER RESEARCH FUND ALLIANCE via OVARIAN CANCER RESEARCH FUND ALLIANCE
2020 · fourth_quarter · Q4
Supporting passage of ongoing appropriations for DoD's OCRP within the CDMRP. Supporting passage of ongoing appropriations for CDC's Johanna's Law and Ovarian Cancer Control Initiative. Supporting passage of ongoing appropriations for NCI.
Supporting passage of H.R.4560 To amend the Public Health Service Act to reauthorize Johanna's Law, and for other purposes. Supporting passage of H.R.913 the CLINICAL TREATMENT Act.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
OVARIAN CANCER RESEARCH FUND ALLIANCE via OVARIAN CANCER RESEARCH FUND ALLIANCE
2020 · third_quarter · Q3
Supporting passage of ongoing appropriations for DoD's OCRP within the CDMRP. Supporting passage of ongoing appropriations for CDC's Johanna's Law and Ovarian Cancer Control Initiative. Supporting passage of ongoing appropriations for NCI.
Supporting passage of H.R.4560 To amend the Public Health Service Act to reauthorize Johanna's Law, and for other purposes. Supporting passage of H.R.913 the CLINICAL TREATMENT Act.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
OVARIAN CANCER RESEARCH FUND ALLIANCE via OVARIAN CANCER RESEARCH FUND ALLIANCE
2020 · second_quarter · Q2
Supporting passage of H.R.4560 To amend the Public Health Service Act to reauthorize Johanna's Law, and for other purposes. Supporting passage of H.R.913 the CLINICAL TREATMENT Act.
Supporting passage of ongoing appropriations for DoD's OCRP within the CDMRP. Supporting passage of ongoing appropriations for CDC's Johanna's Law and Ovarian Cancer Control Initiative. Supporting passage of ongoing appropriations for NCI.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
OVARIAN CANCER RESEARCH FUND ALLIANCE via OVARIAN CANCER RESEARCH FUND ALLIANCE
2020 · first_quarter · Q1
Supporting passage of H.R.4560 To amend the Public Health Service Act to reauthorize Johanna's Law, and for other purposes. Supporting passage of H.R.913 the CLINICAL TREATMENT Act.
Supporting passage of ongoing appropriations for DoD's OCRP within the CDMRP. Supporting passage of ongoing appropriations for CDC's Johanna's Law and Ovarian Cancer Control Initiative. Supporting passage of ongoing appropriations for NCI.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
OVARIAN CANCER RESEARCH FUND ALLIANCE via OVARIAN CANCER RESEARCH FUND ALLIANCE
2019 · fourth_quarter · Q4
Supporting passage of H.R.4560 To amend the Public Health Service Act to reauthorize Johanna's Law, and for other purposes. Supporting passage of H.R.913 the CLINICAL TREATMENT Act.
Supporting passage of ongoing appropriations for DoD's OCRP within the CDMRP. Supporting passage of ongoing appropriations for CDC's Johanna's Law and Ovarian Cancer Control Initiative. Supporting passage of ongoing appropriations for NCI.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
OVARIAN CANCER RESEARCH FUND ALLIANCE via OVARIAN CANCER RESEARCH FUND ALLIANCE
2019 · third_quarter · Q3
Supporting passage of H.R.4560 To amend the Public Health Service Act to reauthorize Johanna's Law, and for other purposes. Supporting passage of H.R.913 the CLINICAL TREATMENT Act.
Supporting passage of ongoing appropriations for DoD's OCRP within the CDMRP. Supporting passage of ongoing appropriations for CDC's Johanna's Law and Ovarian Cancer Control Initiative. Supporting passage of ongoing appropriations for NCI.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
OVARIAN CANCER RESEARCH FUND ALLIANCE via OVARIAN CANCER RESEARCH FUND ALLIANCE
2019 · first_quarter · Q1
Supporting increased funding for CDMRP's OCRP in FY2020 Defense appropriations Support for increased funding fro ovarian cancer reserach and surveillance in FY2020 Labor-HHS-Ed appropriations (no bill # yet) Supporting the introduction of Access to Genetic Counselor Services Act Pursuing additional cosponasors and hearing for Cancer Drug Parity Act of 2019 (S.741/H.R.1730) Pursuing support for CLINICAL TREATMENT Act (H.R.913)
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
OVARIAN CANCER RESEARCH FUND ALLIANCE via OVARIAN CANCER RESEARCH FUND ALLIANCE
2018 · fourth_quarter · Q4
FY19 Appropriations for NIH, CDC, and DoD ovarian cancer programs. Supporting H.R.1409 - Cancer Drug Parity Act of 2017. Supporting the re-authorization of Johanna's Law.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
OVARIAN CANCER RESEARCH FUND ALLIANCE via OVARIAN CANCER RESEARCH FUND ALLIANCE
2018 · third_quarter · Q3
FY19 Appropriations for NIH, CDC, and DoD ovarian cancer programs. Supporting H.R.1409 - Cancer Drug Parity Act of 2017. Supporting the re-authorization of Johanna's Law.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
OVARIAN CANCER RESEARCH FUND ALLIANCE via OVARIAN CANCER RESEARCH FUND ALLIANCE
2018 · second_quarter · Q2
FY19 Appropriations for NIH, CDC, and DoD ovarian cancer programs. Supporting H.R.1409 - Cancer Drug Parity Act of 2017. Supporting the re-authorization of Johanna's Law.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
OVARIAN CANCER RESEARCH FUND ALLIANCE via OVARIAN CANCER RESEARCH FUND ALLIANCE
2018 · first_quarter · Q1
FY18 and FY19 Appropriations for NIH, CDC, and DoD ovarian cancer programs. Supporting H.R.1409 - Cancer Drug Parity Act of 2017. Supporting the re-authorization of Johanna's Law.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
OVARIAN CANCER RESEARCH FUND ALLIANCE via OVARIAN CANCER RESEARCH FUND ALLIANCE
2017 · fourth_quarter · Q4
FY17 and FY18 Appropriations for NIH, CDC, and DoD ovarian cancer programs. Supporting H.R.1409 - Cancer Drug Parity Act of 2017.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
OVARIAN CANCER RESEARCH FUND ALLIANCE via OVARIAN CANCER RESEARCH FUND ALLIANCE
2017 · third_quarter · Q3
FY17 and FY18 Appropriations for NIH, CDC, and DoD ovarian cancer programs. Supporting H.R.1409 - Cancer Drug Parity Act of 2017.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
OVARIAN CANCER RESEARCH FUND ALLIANCE via OVARIAN CANCER RESEARCH FUND ALLIANCE
2017 · second_quarter · Q2
FY17 and FY18 Appropriations for NIH, CDC, and DoD ovarian cancer programs. Supporting H.R.1409 - Cancer Drug Parity Act of 2017.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
OVARIAN CANCER RESEARCH FUND ALLIANCE via OVARIAN CANCER RESEARCH FUND ALLIANCE
2017 · first_quarter · Q1
FY17 and FY18 Appropriations for NIH, CDC, and DoD ovarian cancer programs. Supporting H.R.1409 - Cancer Drug Parity Act of 2017.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE